Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
De Licacy Industrial Co Ltd
TWSE:1464
|
TW |
|
Novartis AG
NYSE:NVS
|
CH |
|
Bunker Hill Mining Corp
OTC:BHLL
|
CA |
|
T
|
TIH Ltd
SGX:T55
|
SG |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
1.3B HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
Glance View
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. engages in the manufacture and distribution of Chinese medicines and pharmaceutical products. The company is headquartered in Tonghua, Jilin. The company went IPO on 2001-05-24. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The firm is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Jilin Province Huinan Changlong Bio-pharmacy Co Ltd’s Gross Margin has decreased from 83.2% to 81.2%. During this period, it reached a low of 81.2% on Sep 30, 2022 and a high of 85.3% on Dec 31, 2020.
